Jump to page content Accessibility
News, views and contacts from the global Drugdevelopment industry
Login to drugdevelopment-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Semagacestat – Gamma Secretase Inhibitor for Alzheimer's Disease



Stages of Alzheimer's disease

There are a number of stages of Alzheimer's disease; the condition runs a course of steady cognitive decline and behavioural issues.

  • Regions of the brain affected in Alzheimer's disease
    Regions of the brain affected in Alzheimer's disease.
  • Stages of Alzheimer's disease
    There are a number of stages of Alzheimer's disease; the condition runs a...
  • Alzheimer's disease
    Alzheimer's is a potentially debilitating disease that has been analysed for...
  • Diagram showing cleavage of APP
    Diagram showing cleavage of APP by proteolytic beta- and gamma-secretase.

Back to Project Details



Related Projects

Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

Erbitux (Cetuximab)
Erbitux is a chimaeric monoclonal antibody (MAb) that is specific for...

Rupintrivir -
Agouron Pharmaceuticals, a subsidiary of Pfizer, has pioneered...

Lipitor / Torcetrapib - Combination Therapy
Under development by Pfizer, torcetrapib is a member of the cholesteryl...

See all projects


Follow Us:
Twitter Twitter    Facebook Facebook   
Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2012 Net Resources International, a trading division of SPG Media Limited.